Non-mental health inpatient and emergency care hospital costs associated with four mental disorders in Europe: a modelling study [0.03%]
欧洲四种精神障碍相关的非精神病住院和急诊医疗费用：一项建模研究
Dennis Wienand,Guy M Goodwin,Judit Simon
Dennis Wienand
Background: The prevalence of physical health conditions is higher among people with mental disorders than the general population, and these conditions have subsequent excess costs. Estimating the magnitude of these exces...
Long-acting oral weekly risperidone (LYN-005) for schizophrenia in the USA (STARLYNG-1): a multicentre, open-label, non-randomised phase 3 trial [0.03%]
长效口服一周一次利培酮（LYN-005）用于美国的精神分裂症患者(STARLYNG-1研究)：一项多中心、开放标签、非随机III期试验
Leslie Citrome,Nayana Nagaraj,Giovanni Traverso et al.
Leslie Citrome et al.
Background: Medication non-adherence and insufficiently managed disease worsen outcomes in people with schizophrenia. We aimed to compare the bioavailability of a long-acting oral weekly formulation of risperidone, LYN-00...
Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in Australia [0.03%]
司来agliptin与安慰剂治疗氯氮平相关肥胖的精神分裂症患者的疗效和安全性（COaST）：在澳大利亚进行的一项二期多中心、患者和研究者均盲目的随机对照试验
Dan Siskind,Andrea Baker,Urska Arnautovska et al.
Dan Siskind et al.
Background: People with schizophrenia have a 16-20-year reduction in life expectancy, primarily due to cardiometabolic disease. Clozapine, the most efficacious antipsychotic for treatment-resistant schizophrenia, is assoc...
An intensive weight loss programme with behavioural support for people with type 2 diabetes at risk of eating disorders in England (ARIADNE): a randomised, controlled, non-inferiority trial [0.03%]
针对糖尿病患者的强化减肥计划并带有行为干预支持的随机对照非劣效性试验（ARIADNE）
Elena Tsompanaki,Paul Aveyard,Rebecca J Park et al.
Elena Tsompanaki et al.
Background: There are concerns that low-energy total diet replacement (TDR) programmes could trigger eating disorders, given their focus on weight and rigid dietary rules. We aimed to assess the effect of a TDR programme ...
Randomized Controlled Trial
The lancet. Psychiatry. 2025 Jul;12(7):483-492. DOI:10.1016/S2215-0366(25)00126-9 2025
International Guidelines for the Algorithmic Treatment of Schizophrenia (INTEGRATE) - Authors' reply [0.03%]
关于精神分裂症的国际算法治疗指南（INTEGRATE)，作者回复）
Robert A McCutcheon,Toby Pillinger,Dan Siskind
Robert A McCutcheon
International Guidelines for the Algorithmic Treatment of Schizophrenia (INTEGRATE) [0.03%]
国际精神分裂症算法治疗指南（整合）
Nicholas Fabiano,David Puder,Joseph Firth et al.
Nicholas Fabiano et al.
Sri Mahavir Agarwal,Margaret Hahn
Sri Mahavir Agarwal
Division and integration [0.03%]
分裂与统一
The Lancet Psychiatry
The Lancet Psychiatry